Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted August 18, 2006
Restitution Program for Purchases of Lane Labs' Products
A federal District Court in Newark, New Jersey has ruled that Lane Labs marketed BeneFin, MGN-3 and SkinAnswer as treatments for cancer, HIV, and skin cancer without FDA approval. See http://www.fda.gov/bbs/topics/news/2004/NEW01086.html .
The Court ordered Lane Labs to pay restitution to persons who purchased the products between September 22, 1999 and July 12, 2004. The Court also appointed Newark, New Jersey attorney Donald A. Robinson as Special Master to oversee the restitution process. Gilardi & Co., LLC has been retained to assist with the restitution process.
For more information, go to the web address below.